Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526) |
---|
09/20/1995 | EP0672156A1 Bovine heat shock promoter and uses thereof |
09/20/1995 | EP0672155A1 A method for obtaining a plant having altered floral morphology and a method for protecting plants against pest insects |
09/20/1995 | EP0672153A1 Vector to deliver and express foreign gene |
09/20/1995 | EP0672152A1 Fusion proteins comprising mgf and il-3 |
09/20/1995 | EP0672151A1 Inhibitors of ced-3 and related proteins |
09/20/1995 | EP0672147A1 Protein conferring an inducible resistance to glycopeptides, particularly in gram-positive bacteria |
09/20/1995 | EP0672146A1 Biocidal chitin binding proteins |
09/20/1995 | EP0672145A1 Interleukin-3 (il-3) multiple mutation polypeptides |
09/20/1995 | EP0672144A1 Interleukin-6 receptor antagonists |
09/20/1995 | EP0672143A1 LYMPHOTOXIN-$g(b), LYMPHOTOXIN-$g(b) COMPLEXES, PHARMACEUTICAL PREPARATIONS AND THERAPEUTIC USES THEREOF |
09/20/1995 | EP0672141A1 Methods of preparing soluble, oligomeric proteins |
09/20/1995 | EP0672140A1 cDNAs ENCODING HUMAN NMDA-22A RECEPTOR SUBUNIT AND ISOFORMS OF THE HUMAN NMDA-R1 RECEPTOR SUBUNIT, TRANSFECTED CELL LINE EXPRESSING THEM |
09/20/1995 | EP0672139A1 Novel polypeptides having opioid receptor activity, nucleic acids coding therefor and uses thereof |
09/20/1995 | EP0672138A1 Chimeric factor viii |
09/20/1995 | EP0672137A1 Gene therapy by retroviral vector with tumor suppressive gene |
09/20/1995 | EP0672136A1 Polypeptides, derived from endonexin 2, having hepatitis b virus receptor activity and their use in diagnostic and pharmaceutical compositions |
09/20/1995 | EP0672135A1 A cell expressing a glutamate receptor |
09/20/1995 | EP0672134A1 Peptides useful for inducing tolerance |
09/20/1995 | EP0672132A1 Receptor internalization signals |
09/20/1995 | EP0672131A1 Interaction trap system for isolating novel proteins |
09/20/1995 | EP0672130A1 Peptide corresponding to cd44 exon 6, antibodies specific for said peptide and use of these antibodies for diagnosis of tumors |
09/20/1995 | EP0672129A1 Cell-type specific gene transfer using retroviral vectors containing antibody-envelope fusion proteins |
09/20/1995 | EP0672128A1 Stem cell proliferation factor |
09/20/1995 | EP0672127A1 Use of thiol redox proteins for reducing disulfide bonds |
09/20/1995 | EP0672123A1 Multifunctional surface protein of streptococci |
09/20/1995 | EP0672119A1 Retroviral mediated transfer of the human multiple drug resistance gene |
09/20/1995 | EP0672118A1 A novel b-lymphoma cell line and antigen |
09/20/1995 | EP0672116A1 Deletion mutants as vaccines for cholera |
09/20/1995 | EP0672067A1 Dna encoding a prostaglandin receptor, a host cell transformed therewith and an expression product thereof |
09/20/1995 | EP0672066A1 Peptides from the c33 region of hcv, antibodies thereto and methods for the detection of hcv |
09/20/1995 | EP0672065A1 Hepatitis c virus (hcv) non-structural-3 peptides, antibodies thereto and methods for the detection of hcv |
09/20/1995 | EP0672064A1 Op-3-induced morphogenesis |
09/20/1995 | EP0672061A1 Receptor for oncostatin m and leukemia inhibitory factor |
09/20/1995 | EP0672060A1 Antigen associated with type i diabetes mellitus |
09/20/1995 | EP0672059A1 CYCLIC COMPOUNDS LINKED BY A HETEROCYCLIC RING USEFUL AS INHIBITORS OF PLATELET GLYCOPROTEIN IIb/IIIa |
09/20/1995 | EP0672058A1 Calcium channel blocking polypeptides from heteropoda venatoria |
09/20/1995 | EP0672057A1 Analogs of pth |
09/20/1995 | EP0672055A1 Neuropeptide y antagonists |
09/20/1995 | EP0672054A1 A novel molecule which inhibits neuropeptide tyrosine biological function |
09/20/1995 | EP0672053A1 Treatment of septic shock with conjugated biologically active peptides |
09/20/1995 | EP0672051A1 PURIFICATION OF KRINGLE CONTAINING PROTEINS, AND ESPECIALLY t-PA |
09/20/1995 | EP0672050A1 Method of recovering endothelial membrane from tissue and applications thereof |
09/20/1995 | EP0672048A1 THE tagA GENE AND METHODS FOR DETECTING PREDISPOSITION TO PEPTIC ULCERATION |
09/20/1995 | EP0671949A1 USE OF $g(b)-CELL-TROPIN (ACTH 22-39) ANTAGONISTS IN THE TREATMENT OF TYPE II DIABETES AND ASSOCIATED DISEASES |
09/20/1995 | EP0671947A1 Compositions for eliciting cytotoxic t-lymphocyte responses against viruses |
09/20/1995 | EP0671946A1 Immunoreactive peptides from epstein-barr virus |
09/20/1995 | EP0671945A1 Methods and compositions for the modulation of host immune response to allergens |
09/20/1995 | EP0671944A1 Bovine pancreatic trypsin inhibitor derived inhibitors of factor viia-tissue factor complex |
09/20/1995 | EP0671940A1 Insulin-like peptide |
09/20/1995 | EP0671939A1 Treatment of dermatological malignancies with biologically active peptides |
09/20/1995 | EP0671938A1 Novel biologically active peptides and uses therefor |
09/20/1995 | EP0671936A1 TREATMENT OF INSULIN RESISTANCE IN OBESITY LINKED TYPE II DIABETES USING ANTAGONISTS TO TNF-$g(a) FUNCTION |
09/20/1995 | EP0671934A1 Method of treating cell damage or depletion |
09/20/1995 | EP0671932A1 Cytokine applications |
09/20/1995 | EP0671931A1 Hemoregulatory peptides |
09/20/1995 | EP0671930A1 Prophylaxis and treatment of adverse oral conditions with biologically active peptides |
09/20/1995 | EP0671928A1 Synthesis of n-substituted oligomers |
09/20/1995 | EP0671926A1 Immunomodulatory peptides |
09/20/1995 | EP0671921A1 Method for crosslinking of haemoglobin and use of such crosslinked haemoglobin |
09/20/1995 | EP0671909A1 Syndecan stimulation of cellular differentiation |
09/20/1995 | EP0671902A1 $i(CLOSTRIDIAL) TOXIN DISEASE THERAPY |
09/20/1995 | EP0671879A1 Prevention of retinal injury and degeneration by specific factors |
09/20/1995 | EP0643778A4 Encoded combinatorial chemical libraries. |
09/20/1995 | EP0540591B1 Cell necrosis detection through assays for spectrin and breakdown products thereof |
09/20/1995 | EP0474662B1 Bacillus thuringiensis gene, protein and its use |
09/20/1995 | EP0429644B1 Chelating agents for attaching metal ions to proteins |
09/20/1995 | EP0326595B1 Peptides and antibodies that inhibit platelet adhesion |
09/20/1995 | CN1108663A Method for preparation of cardiac muscle cell growth stimulus peptide |
09/20/1995 | CN1108662A Method of producing reconstituted lipoproteins |
09/20/1995 | CN1029784C Method of chain combination |
09/19/1995 | US5451669 DNA encoding for an Fc receptor for immunoglobulin |
09/19/1995 | US5451664 Acta and methods for detecting the same |
09/19/1995 | US5451662 Method of purifying protein |
09/19/1995 | US5451660 Method for purifying polypeptides |
09/19/1995 | US5451659 Polypeptide, DNA fragment encoding the same, drug composition containing the same and process for producing the same |
09/19/1995 | US5451658 Antagonists of human gamma interferon |
09/19/1995 | US5451572 Human relaxin formulation |
09/19/1995 | US5451527 HCG peptides for use in antibody purification procedures |
09/19/1995 | US5451521 Procoagulant proteins |
09/19/1995 | US5451506 Oncostatin M and novel compositions having anti-neoplastic activity |
09/19/1995 | US5451499 Attenuated, genetically-engineered pseudorabies virus S-PRV-155 and uses thereof |
09/19/1995 | US5451411 Polyacrylic acid, crosslinked alginate |
09/19/1995 | US5451399 [ALA IL-8]77 and [SER IL-8]72 as Leukocyte adhesion inhibitors |
09/19/1995 | CA1337050C Monoclonal antibody selectively binding to novel g-csf derivative |
09/19/1995 | CA1337048C Process for the production of biologically active peptide via the expression of modified storage seed protein genes in transgenic plants |
09/19/1995 | CA1337024C Method for stabilizing taste-modifier |
09/18/1995 | CA2144576A1 A single step purification of recombinant human interleukin-5 |
09/17/1995 | CA2144569A1 Peptides for inhibiting pepsin release |
09/14/1995 | WO1995024501A1 Compositions for the inhibition of tnf formation and uses thereof |
09/14/1995 | WO1995024493A1 Enhanced expression in a plant plastid |
09/14/1995 | WO1995024492A1 Expression of bacillus thuringiensis cry proteins in plant plastids |
09/14/1995 | WO1995024490A1 Cell surface protein and effector cell bonding reagent |
09/14/1995 | WO1995024486A1 ANTIMICROBIAL PROTEINS FROM ARALIA AND $i(IMPATIENS) |
09/14/1995 | WO1995024485A2 Coordinate in vivo gene expression |
09/14/1995 | WO1995024480A1 Fk506-binding protein gene |
09/14/1995 | WO1995024479A1 Novel thiol protease inhibitor |
09/14/1995 | WO1995024478A1 Synthetic proteins as implantables |
09/14/1995 | WO1995024476A1 Method of cloning |
09/14/1995 | WO1995024475A1 Vaccine compositions |
09/14/1995 | WO1995024474A1 Bone morphogenic protein-10 |